The Singapore Exchange (SGX) released its first batch of in-house stock indexes yesterday as part of a strategy to enable more exchange- traded fund (ETF) products to be issued here. The SGX S-Reit (real estate investment trust) 20 Index, for example, measures the performance of the 20 largest and most tradable S-Reits while the SGX All Healthcare Index tracks 29 shares, including healthcare providers, medical manufacturers and biotech firms. The new push is already showing results, with SGX in talks with potential issuers over an S-Reit ETF, which is expected to enter the market in six months' time.
The Straits Times,Dec 2, 2015, 5:00 am SGT
新加坡交易所(SGX)昨日公佈了第一批由新交所自製的自製性指數,以作為一項刺激ETF在此掛牌的新戰略。 例如S-Reit(新加坡不動產投資信託) 20指數,追蹤的是在新交所上市的前20大藍籌REITs的表現,而新交所全市場生技醫療產業指數(SGX All Healthcare Index)追踪的是由29股組成,包括醫療服務提供者、醫療設備製造商和生物科技公司等有關生技醫療的優質公司。 值得注意的是,有些新推的指數已初具成效,例如近期已有潛在ETF發行者與新交所談判,有望在半年內(按:2016年6月左右)推出一隻追蹤S-Reit的新ETF。
這則新聞也代表了:SGX已經在跟ETF發行者洽商,將推出新加坡REITs的ETF,這真是一件令人振奮的事!而依據Phillip Singapore Real Estate Income Fund的殖利率5.13%來看,這檔ETF將會有5%以上的報酬,真是值得期待!至於複委託是否可以買入招募中ETF(ETF under IPO)則需要再問券商。但有件事是確定的:以後可以用一隻ETF投資一籃子的REIT,而無須選股或逐一買入,It's great,isn't it?